1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with formycins in 1 studies
Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (formycins) | Trials (formycins) | Recent Studies (post-2010) (formycins) |
---|---|---|---|---|---|
9,156 | 187 | 552 | 303 | 0 | 19 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Takeda, K | 1 |
1 review(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and formycins
Article | Year |
---|---|
[Role of increase in permeability and circulatory failure in the development of organ dysfunction in severe acute pancreatitis].
Topics: Acute Disease; Animals; Bradykinin; Capillary Permeability; Formycins; Histamine; Humans; Interleukin-1; Microcirculation; Neutrophil Infiltration; Pancreatitis; Platelet Activating Factor; Ribonucleotides; Severity of Illness Index; Shock; Thrombin; Thrombophilia; Tumor Necrosis Factor-alpha | 2004 |